MS-DRG 014Medical
Allogeneic Bone Marrow Transplant
Pre-MDC·Grouped by diagnosis·FY 2027
MS-DRG 014 is a Medical Medicare Severity Diagnosis Related Group. For FY 2027 it carries a relative weight of 11.7942 with a geometric mean length of stay of 26 days and an arithmetic mean of 29 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
Advertisements
FY 2027 payment data
From Table 5 of the FY 2027 IPPS Final Rule (CMS).
- Relative weight:
- 11.7942 (payment multiplier vs. the average case (1.0))
- Geometric mean stay:
- 26 days (used for transfer payments)
- Average stay:
- 29 days (arithmetic mean)
- Post-acute transfer policy:
- No (not subject to it)
Procedure codes (26)
ICD-10-PCS procedures that can group a stay to DRG 014.
- 30233G2Transfusion of Allogeneic Related Bone Marrow into Peripheral Vein, Percutaneous Approach
- 30233G3Transfusion of Allogeneic Unrelated Bone Marrow into Peripheral Vein, Percutaneous Approach
- 30233G4Transfusion of Allogeneic Unspecified Bone Marrow into Peripheral Vein, Percutaneous Approach
- 30233U2Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
- 30233U3Transfusion of Allogeneic Unrelated T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
- 30233U4Transfusion of Allogeneic Unspecified T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
- 30233X2Transfusion of Allogeneic Related Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
- 30233X3Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
- 30233X4Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
- 30233Y2Transfusion of Allogeneic Related Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
- 30233Y3Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
- 30233Y4Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
- 30243G2Transfusion of Allogeneic Related Bone Marrow into Central Vein, Percutaneous Approach
- 30243G3Transfusion of Allogeneic Unrelated Bone Marrow into Central Vein, Percutaneous Approach
- 30243G4Transfusion of Allogeneic Unspecified Bone Marrow into Central Vein, Percutaneous Approach
- 30243U2Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
- 30243U3Transfusion of Allogeneic Unrelated T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
- 30243U4Transfusion of Allogeneic Unspecified T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
- 30243X2Transfusion of Allogeneic Related Cord Blood Stem Cells into Central Vein, Percutaneous Approach
- 30243X3Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Central Vein, Percutaneous Approach
- 30243X4Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Central Vein, Percutaneous Approach
- 30243Y2Transfusion of Allogeneic Related Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
- 30243Y3Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
- 30243Y4Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
- XW133C8Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW143C8Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8